A Comparison of Antiarrhythmic Drug Therapy and Radio Frequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation
A Randomized Comparison of the Efficacy of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation for the Maintenance of Sinus Rhythm In Patients With Paroxysmal Atrial Fibrillation
Sponsor: Biosense Webster, Inc.
A PHASE4 clinical study on Paroxysmal Atrial Fibrillation, this trial is completed. The trial is conducted by Biosense Webster, Inc. and has accumulated 9 data snapshots since 2003. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
9 versions recorded-
Mar 2025 — Present [monthly]
Completed PHASE4
-
Feb 2025 — Mar 2025 [monthly]
Completed PHASE4
-
Jan 2025 — Feb 2025 [monthly]
Completed PHASE4
-
Sep 2024 — Jan 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
▶ Show 4 earlier versions
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE4
First recorded
Aug 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Biosense Webster, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .